Navigation Links
Perrigo Reports Record Fourth Quarter and Fiscal Year Revenue and Earnings
Date:8/15/2013

es of existing products (gastrointestinal and analgesics categories) and $1 million in discontinued products.

Fourth quarter adjusted gross margin expanded 410 basis points due to the inclusion of Sergeant's and Velcera, new products, increased manufacturing efficiencies and a favorable product mix. Fourth quarter operating expenses increased due primarily to incremental operating expenses from the acquisitions of Sergeant's and Velcera.

Nutritionals

Nutritionals Segment 4Q Results
(dollars in millions)
(see the attached Table II for reconciliation to GAAP numbers)Fiscal 2013

Fiscal 2012 

Fourth
Quarter

Ended

Fourth
Quarter

Ended

 

 

YoY6/29/2013

6/30/2012

% Change*Net Sales

$149.7

$135.3

+10.6%Reported Gross Profit

$40.1

$37.2

+7.9%Adjusted Gross Profit

$43.2

$40.2

+7.4%Reported Operating Income

$17.2

$11.8

+45.5%Adjusted Operating Income

$24.5

$20.1

+21.7%Reported Gross Margin

26.8%

27.5%

-70 bpsAdjusted Gross Margin

28.9%

29.7%

-90 bpsReported Operating Margin

11.5%

8.7%

+280 bpsAdjusted Operating Margin

16.4%

14.9%

+150 bpsThe Nutritionals segment reported fourth quarter net sales of $150 million, compared with $135 million a year ago, an increase of 11%. All product categories within the segment grew year-over-year and new product sales were $7 million. The difference between the reported and adjusted operating income and margin was due to the absence of restructuring charges incurred in the fourth quarter of fiscal 2012 related to the Company's Florida location, which was closed in the fourth quarter of fiscal 2012.

Fourth quarter adjusted gross margin decreased due primarily to
'/>"/>

SOURCE Perrigo
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27

Related medicine technology :

1. Perrigo Nutritionals Works with the American Academy of Pediatrics (AAP) on Infant Nutrition Educational Initiative
2. Perrigo Company Will Release Fourth Quarter And Fiscal Year 2013 Results On August 15, 2013
3. Perrigo Receives FDA Tentative Approval For Generic Equivalent To Prandin(R)
4. Perrigo Company Acquires Ophthalmic Product Portfolio From Fera Pharmaceuticals, LLC For An Upfront Payment Of $93 Million
5. New Breakthroughs Allow Companies to Expand their Reach - Research Report on Perrigo, Auxilium, Actavis, Mylan, and Salix
6. Perrigo Launches First-Ever Industry Marketing Campaign For Store Brand OTC Medications
7. Perrigo Reports Record Revenue and Adjusted Earnings
8. Perrigo Company To Release Third Quarter Fiscal Year 2013 Results On May 7, 2013
9. Perrigo Company To Present At The Barclays Global Healthcare Conference
10. Perrigo Company To Present At The RBC Global Healthcare Conference
11. Perrigo Confirms First to File Patent Challenge for Generic Version of Testosterone Gel 1.62%
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)...  Pete Rose, baseball,s all-time hits leader, is the new spokesperson ... Ducere Pharma has announced. "Pete,s a Hall of ... him on board with Myoflex," said Ducere Pharma Chief Executive ... who is known across all generations. The passion and intensity ...
(Date:1/23/2015)... , Jan. 23, 2015  Lixte Biotechnology Holdings, Inc. (OTCQB: ... Phase I trial of Lixte,s lead compound, LB‑100, is being ... John S. Kovach , M.D., the founder and ... to be completed at a single site. Accrual of patients, ...
(Date:1/23/2015)... plc (NYSE: MNK ) announced today that ... program. The open-ended authorization permits the company to repurchase ... "Funding additional initiatives and seeking attractive ... to pursue a range of focused growth strategies," said ...
Breaking Medicine Technology:Pete Rose bets on Myoflex to relieve aches and pains 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3Mallinckrodt plc Announces Share Repurchase Program 2Mallinckrodt plc Announces Share Repurchase Program 3Mallinckrodt plc Announces Share Repurchase Program 4
... 24,544 terms, including genetic testing and device software , ... PLYMOUTH MEETING, Pa. , July 8 ... the expansion of its database to include thousands of new terms for medical devices, ... , , The ...
... FRANCISCO, Calif. , July 8 iPierian, ... stem cells (iPSCs) for drug discovery, today announced the ... equity financing.  The financing round was led by new ... Capital and ATEL Ventures.  All current investors also participated, ...
Cached Medicine Technology:ECRI Institute Adds 4,000 New Terms to Universal Medical Device Nomenclature System™ 2ECRI Institute Adds 4,000 New Terms to Universal Medical Device Nomenclature System™ 3ECRI Institute Adds 4,000 New Terms to Universal Medical Device Nomenclature System™ 4iPierian Closes $22 Million Series B Financing Led By Google Ventures 2iPierian Closes $22 Million Series B Financing Led By Google Ventures 3
(Date:1/22/2015)... 2015 Padre Murphy's and Owner Tom Boyle ... Pro Player Health Alliance (PPHA). The PPHA's passion for ... everyone, including NFL greats, treated for obstructive sleep apnea (OSA) ... supporting the cause in the valley. The most recent plans ...
(Date:1/22/2015)... AngelWeddingDress, the premier women’s dress supplier, has recently ... View website of AngelWeddingDress.com to find more details. ... online for a bridal party. AngelWeddingDress offers a variety ... Its maternity wedding dresses are specially designed for 2015. ...
(Date:1/22/2015)... Autocarinsurancebest.com has released a new blog post explaining the ... . , Auto insurance quotes help many drivers find ... necessary to call an agent or visit an agency for ... single website: http://autocarinsurancebest.com/ . , Every business who relies ...
(Date:1/22/2015)... 2015 Yesterday, Senator Holly Mitchell ... Kristin Olsen (R-Modesto) were honored by the California ... biotechnology, biomedical science, medical device and pharmaceutical innovation ... the “2014 Life Sciences Champion” award from CHI ...
(Date:1/22/2015)... 22, 2015 EBSCO Information Services ... expanding their relationship in an effort to further promote visibility ... While EBSCO has long made AMA journals available via its ... for The JAMA Network. , Long known as ...
Breaking Medicine News(10 mins):Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 3Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4
... about microRNAs short strands of RNA that can ... it becomes how closely they are associated with cancer. ... and their colleagues have identified two microRNAs (miRNAs) that ... miRNAs may provide an early warning of metastatic breast ...
... findings apply to humans , , MONDAY, Jan. 28 (HealthDay News) ... a new study found. , The mice that were breast-fed ... the allergen and developed tolerance to it. , But once ... can be extrapolated to humans. , "You hate to ...
... 28 MaxCyte, Inc., a,clinical-stage therapeutic company ... systems, announces that Madhusudan V. Peshwa, Ph.D., ... present on Tuesday,January 29, 2008, at 11:35 ... Therapy,Forum in Washington, DC. Dr. Peshwa,s presentation ...
... of,President Bush,s final State of the Union address this ... that,should be undertaken this year to protect our nation,s ... unstable economy, the growing health,care crisis and very real ... on the president and Congress to:, -- Increase ...
... A new study, led by researchers at The ... that certain over-the-counter earwax softeners can cause severe inflammation ... results of the study, recently published in The Laryngoscope, ... , Patients often complain that wax is blocking their ...
... Preventive Medicine (ACPM) has found there is insufficient ... prostate screening with digital rectal examination (DRE) or ... (PSA). ACPM advises that clinicians caring for ... family history, should provide information about the potential ...
Cached Medicine News:Health News:2 microRNAs promote spread of tumor cells 2Health News:2 microRNAs promote spread of tumor cells 3Health News:Breast-Feeding Protected Mice From Asthma 2Health News:Breast-Feeding Protected Mice From Asthma 3Health News:MaxCyte to Present at the Phacilitate Cell and Gene Therapy Forum 2008 2Health News:APHA Says Investing in Healthy People and Communities Can Help Create a Healthy Economy 2
... Designed and manufactured specifically ... MultiWash II delivers the ... demand. The MultiWash II ... dependable accuracy, while providing ...
... the determination of A1c is also designed to ... is a fully automated analyzer including primary tube ... in safety and positive identification. The analysis methodology ... be interference-free and to produce the lowest CV's ...
Micromat II Hemoglobin A1c instrument is an easy-to-use, accurate and precise instrument with an requirement of only 10 L of capillary or venous sample....
... Cascade M-4 is a manual hemostasis ... routine clotting assays - PTs, aPTTs, ... for easy, inexpensive, low-volume testing, this ... big on features, offering time and ...
Medicine Products: